Article metrics

Original research
Translational randomized phase II trial of cabozantinib in combination with nivolumab in advanced, recurrent, or metastatic endometrial cancer

 

Online download statistics by month:

Online download statistics by month: March 2022 to September 2022

AbstractFullPdf
Mar 2022551568274
Apr 2022275286121
May 2022219221106
Jun 202222323492
Jul 202220521877
Aug 202221922369
Sep 2022235238225
Total19271988964